Inventor
PIPPEL DANIEL J
US34 patents
⚠️ This page may combine multiple inventors who share the name “PIPPEL DANIEL J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
27 patentsUS7507737B2Mar 24, 2009
Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4receptor
JANSSEN PHARMACEUTICA NV37 citations96
US9079911B2Jul 14, 2015
Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
JANSSEN PHARMACEUTICA NV13 citations92
US8598189B2Dec 3, 2013
Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor
JANSSEN PHARMACEUTICA NV12 citations92
US8343989B2Jan 1, 2013
Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor
JANSSEN PHARMACEUTICA NV10 citations84
US11059828B2Jul 13, 2021
Disubstituted octahydropyrrolo[3,4-C]pyrroles as orexin receptor modulators
JANSSEN PHARMACEUTICA NV3 citations83
US9079866B2Jul 14, 2015
Flap modulators
JANSSEN PHARMACEUTICA NV8 citations83
US11667644B2Jun 6, 2023
Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
JANSSEN PHARMACEUTICA NV2 citations72
USRE48841EDec 7, 2021
Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
JANSSEN PHARMACEUTICA NV2 citations72
US8952177B2Feb 10, 2015
1,2,6-substituted benzimidazoles as FLAP modulators
JANSSEN PHARMACEUTICA NV4 citations72
US11254673B2Feb 22, 2022
Small molecule inhibitors of NF-κB inducing kinase
JANSSEN PHARMACEUTICA NV2 citations69
US12378254B2Aug 5, 2025
Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
JANSSEN PHARMACEUTICA NV0 citations62
US9089569B2Jul 28, 2015
1,2,6-substituted benzimidazoles as flap modulators
JANSSEN PHARMACEUTICA NV3 citations62
US8962644B2Feb 24, 2015
Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor
JANSSEN PHARMACEUTICA NV2 citations62
US11827634B2Nov 28, 2023
Small molecule inhibitors of NF-kB inducing kinase
JANSSEN PHARMACEUTICA NV0 citations60
US9518021B2Dec 13, 2016
Process for the preparation of histamine H3 receptor modulators
JANSSEN PHARMACEUTICA NV1 citations59
US9365548B2Jun 14, 2016
Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor
JANSSEN PHARMACEUTICA NV0 citations52
US9884878B2Feb 6, 2018
FLAP modulators
JANSSEN PHARMACEUTICA NV1 citations51
US9745328B2Aug 29, 2017
Flap modulators
JANSSEN PHARMACEUTICA NV1 citations51
US9695149B2Jul 4, 2017
1,2,6-substituted benzimidazoles as flap modulators
JANSSEN PHARMACEUTICA NV0 citations51
US9359327B2Jun 7, 2016
Process for the preparation of substituted pyrimidine derivatives
JANSSEN PHARMACEUTICA NV0 citations51
US9079882B2Jul 14, 2015
Process for the preparation of substituted pyrimidine derivatives
JANSSEN PHARMACEUTICA NV0 citations51
US9079883B2Jul 14, 2015
Process for the preparation of substituted pyrimidine derivatives
JANSSEN PHARMACEUTICA NV0 citations51
US9079884B2Jul 14, 2015
Process for the preparation of substituted pyrimidine derivatives
JANSSEN PHARMACEUTICA NV0 citations51
US9006432B2Apr 14, 2015
Process for the preparation of substituted pyrimidine derivatives
JANSSEN PHARMACEUTICA NV0 citations51
US10323002B2Jun 18, 2019
Process for the preparation of histamine H3 receptor modulators
JANSSEN PHARMACEUTICA NV0 citations49
US9809547B2Nov 7, 2017
Process for the preparation of histamine H3 receptor modulators
JANSSEN PHARMACEUTICA NV0 citations49
US9371311B2Jun 21, 2016
Benzoimidazol-2-yl pyrimidine derivatives
JANSSEN PHARMACEUTICA NV1 citations44